Tylenol's parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.
We are sharing Tech and Health related news from all around the world. hope that these content will serve the purpose.
No comments:
Post a Comment